Sanofi Names Belén Garijo as Next CEO After Hudson Exit
Sanofi’s board has appointed Belén Garijo as Chief Executive Officer, with the transition set to take place after the company’s annual general meeting on April 29, 2026. Paul Hudson will step down on February 17, 2026, after the board chose not to renew his director mandate. During the interim period, Olivier Charmeil, Executive Vice President of General Medicines and a long-time member of the executive committee, will serve as interim CEO…